The Effect of Liraglutide on the Treatment of Coronary Artery Disease and Type 2 Diabetes (AddHope2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01595789
Recruitment Status : Completed
First Posted : May 10, 2012
Last Update Posted : March 7, 2017
Information provided by (Responsible Party):
Haugaard, Steen Bendix, M.D., DMSc

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : October 2014
  Actual Study Completion Date : July 2015
Publications automatically indexed to this study by Identifier (NCT Number):